This was supported by in silico analyses and mining of published CRC patient data sets, revealing significant correlation between TAN markers (S100A8, S100A9, SPP1, and MMP14) and established EC genes (PECAM1, VWF, and CDH5). The gene discussed is S100A9; the disease is colorectal carcinoma.